Australia Markets closed

Analytica Limited (ALT.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.00300.0000 (0.00%)
At close: 10:20AM AEDT

Analytica Limited

320 Adelaide Street
Brisbane, QLD 4000
Australia
61 7 3278 1950
http://www.analyticamedical.com

Sector(s)Healthcare
IndustryMedical Devices
Full-time employees2

Key executives

NameTitlePayExercisedYear born
Dr. Michael MonsourExec. Chairman82.12kN/AN/A
Mr. Geoff Daly BE (Hons, Mech, UQ), MBA (Exec, AGSM), MIEAust CPEChief Exec. Officer282.88kN/AN/A
Mr. Ross Mangelsdorf B.Bus, FCA, CTA, FTIA, MAICDCFO & Exec. Director192.72kN/AN/A
Ms. Chelsea CorneliusProduct Devel. & Operations Mang.N/AN/AN/A
Ms. Megan HenkenVP of Global MarketingN/AN/AN/A
Mr. Bryan Dulhunty C.A., BEc, ACACompany Sec.N/AN/AN/A
Amounts are as of 31 December 2020, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.

Description

Analytica Limited designs, develops, and supplies medical devices in Australia, the United Kingdom, and the United States. The company's lead product is PeriCoach system, an e-health treatment system for women used in treatment of stress urinary incontinence. Its PeriCoach comprises a device, Web portal, and smartphone app for evaluating activity in pelvic floor muscles. The company also provides Autostart Burette Infusion System for monitoring and refilling of burettes in intravenous fluid infusion. Analytica Limited was incorporated in 1985 and is based in Brisbane, Australia.

Corporate governance

Analytica Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.